ACCENT MICROCELL LTD. | LACTOSE INDIA | ACCENT MICROCELL LTD./ LACTOSE INDIA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | - | 27.6 | - | View Chart |
P/BV | x | 3.3 | 5.5 | 59.6% | View Chart |
Dividend Yield | % | 0.4 | 0.0 | - |
ACCENT MICROCELL LTD. LACTOSE INDIA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
ACCENT MICROCELL LTD. Mar-24 |
LACTOSE INDIA Mar-24 |
ACCENT MICROCELL LTD./ LACTOSE INDIA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 364 | 174 | 209.6% | |
Low | Rs | 224 | 40 | 559.4% | |
Sales per share (Unadj.) | Rs | 116.7 | 90.5 | 129.0% | |
Earnings per share (Unadj.) | Rs | 14.3 | 5.4 | 265.9% | |
Cash flow per share (Unadj.) | Rs | 16.4 | 9.5 | 172.4% | |
Dividends per share (Unadj.) | Rs | 1.00 | 0 | - | |
Avg Dividend yield | % | 0.3 | 0 | - | |
Book value per share (Unadj.) | Rs | 77.9 | 37.4 | 208.1% | |
Shares outstanding (eoy) | m | 21.04 | 12.59 | 167.1% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 2.5 | 1.2 | 213.4% | |
Avg P/E ratio | x | 20.5 | 19.8 | 103.5% | |
P/CF ratio (eoy) | x | 17.9 | 11.2 | 159.6% | |
Price / Book Value ratio | x | 3.8 | 2.9 | 132.2% | |
Dividend payout | % | 7.0 | 0 | - | |
Avg Mkt Cap | Rs m | 6,187 | 1,345 | 459.9% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 110 | 87 | 126.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 2,455 | 1,139 | 215.6% | |
Other income | Rs m | 36 | 12 | 314.6% | |
Total revenues | Rs m | 2,491 | 1,150 | 216.5% | |
Gross profit | Rs m | 385 | 190 | 202.8% | |
Depreciation | Rs m | 44 | 52 | 84.9% | |
Interest | Rs m | 11 | 52 | 21.9% | |
Profit before tax | Rs m | 365 | 97 | 378.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 64 | 29 | 221.2% | |
Profit after tax | Rs m | 302 | 68 | 444.4% | |
Gross profit margin | % | 15.7 | 16.7 | 94.1% | |
Effective tax rate | % | 17.4 | 29.7 | 58.5% | |
Net profit margin | % | 12.3 | 6.0 | 206.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 1,721 | 355 | 484.2% | |
Current liabilities | Rs m | 465 | 254 | 183.0% | |
Net working cap to sales | % | 51.2 | 8.9 | 574.9% | |
Current ratio | x | 3.7 | 1.4 | 264.6% | |
Inventory Days | Days | 16 | 34 | 46.2% | |
Debtors Days | Days | 800 | 493 | 162.1% | |
Net fixed assets | Rs m | 414 | 652 | 63.5% | |
Share capital | Rs m | 210 | 126 | 167.2% | |
"Free" reserves | Rs m | 1,428 | 345 | 413.8% | |
Net worth | Rs m | 1,638 | 471 | 347.9% | |
Long term debt | Rs m | 15 | 242 | 6.2% | |
Total assets | Rs m | 2,135 | 1,007 | 211.9% | |
Interest coverage | x | 32.9 | 2.8 | 1,155.8% | |
Debt to equity ratio | x | 0 | 0.5 | 1.8% | |
Sales to assets ratio | x | 1.2 | 1.1 | 101.7% | |
Return on assets | % | 14.7 | 11.9 | 122.9% | |
Return on equity | % | 18.4 | 14.4 | 127.7% | |
Return on capital | % | 22.8 | 20.9 | 109.0% | |
Exports to sales | % | 58.8 | 0 | - | |
Imports to sales | % | 0.8 | 29.3 | 2.7% | |
Exports (fob) | Rs m | 1,444 | NA | - | |
Imports (cif) | Rs m | 20 | 334 | 5.9% | |
Fx inflow | Rs m | 1,444 | 286 | 504.6% | |
Fx outflow | Rs m | 32 | 345 | 9.4% | |
Net fx | Rs m | 1,412 | -59 | -2,399.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 113 | 88 | 129.1% | |
From Investments | Rs m | -823 | -21 | 3,960.7% | |
From Financial Activity | Rs m | 723 | -57 | -1,257.4% | |
Net Cashflow | Rs m | 13 | 9 | 133.0% |
Indian Promoters | % | 55.1 | 53.7 | 102.7% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.6 | 271.0% | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 44.9 | 46.4 | 96.9% | |
Shareholders | 2,999 | 16,998 | 17.6% | ||
Pledged promoter(s) holding | % | 0.0 | 26.1 | - |
Compare ACCENT MICROCELL LTD. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB MANKIND PHARMA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | ACCENT MICROCELL LTD. | LACTOSE INDIA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.75% | 4.98% | 0.04% |
1-Month | 0.42% | 21.53% | -0.91% |
1-Year | -12.35% | 133.08% | 45.08% |
3-Year CAGR | -4.30% | 71.52% | 19.09% |
5-Year CAGR | -2.60% | 62.07% | 25.76% |
* Compound Annual Growth Rate
Here are more details on the ACCENT MICROCELL LTD. share price and the LACTOSE INDIA share price.
Moving on to shareholding structures...
The promoters of ACCENT MICROCELL LTD. hold a 55.1% stake in the company. In case of LACTOSE INDIA the stake stands at 53.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ACCENT MICROCELL LTD. and the shareholding pattern of LACTOSE INDIA.
Finally, a word on dividends...
In the most recent financial year, ACCENT MICROCELL LTD. paid a dividend of Rs 1.0 per share. This amounted to a Dividend Payout ratio of 7.0%.
LACTOSE INDIA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of ACCENT MICROCELL LTD., and the dividend history of LACTOSE INDIA.
For a sector overview, read our pharmaceuticals sector report.
Indian benchmark indices reversed the trend as the session progressed and ended the day higher.